These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27148623)

  • 1. Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics.
    Low KE; Ler S; Chen KJ; Campbell RL; Hickey JL; Tan J; Scully CC; Davies PL; Yudin AK; Zaretsky S
    J Med Chem; 2016 Jun; 59(11):5403-15. PubMed ID: 27148623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of allosteric calpain-1 inhibitors populating a novel bioactivity space.
    Kalash L; Cresser-Brown J; Habchi J; Morgan C; Miller DJ; Glen RC; Allemann RK; Bender A
    Eur J Med Chem; 2018 Sep; 157():1264-1275. PubMed ID: 30195237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiproliferative activity of sulfonamide-based peptidomimetic calpain inhibitors.
    Donkor IO; Xu J; Liu J; Cameron K
    Bioorg Med Chem; 2020 May; 28(9):115433. PubMed ID: 32199690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of thalassospiramides, a new class of calpain inhibitors.
    Lu L; Meehan MJ; Gu S; Chen Z; Zhang W; Zhang G; Liu L; Huang X; Dorrestein PC; Xu Y; Moore BS; Qian PY
    Sci Rep; 2015 Mar; 5():8783. PubMed ID: 25740631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine.
    Chen H; Jiao W; Jones MA; Coxon JM; Morton JD; Bickerstaffe R; Pehere AD; Zvarec O; Abell AD
    Chem Biodivers; 2012 Nov; 9(11):2473-84. PubMed ID: 23161629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpains: attractive targets for the development of synthetic inhibitors.
    Pietsch M; Chua KC; Abell AD
    Curr Top Med Chem; 2010; 10(3):270-93. PubMed ID: 20166953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-heterocyclic dipeptide aldehyde calpain inhibitors.
    Jones SA; Jones MA; McNabb SB; Aitken SG; Coxon JM; Abell AD
    Protein Pept Lett; 2009; 16(12):1466-72. PubMed ID: 20001909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated patent review of calpain inhibitors (2012 - 2014).
    Donkor IO
    Expert Opin Ther Pat; 2015 Jan; 25(1):17-31. PubMed ID: 25399719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
    Hanna RA; Campbell RL; Davies PL
    Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new cell-permeable calpain inhibitor.
    Fiorino F; Gil-Parrado S; Assfalg-Machleidt I; Machleidt W; Moroder L
    J Pept Sci; 2007 Jan; 13(1):70-3. PubMed ID: 17019744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpain inhibitors: a survey of compounds reported in the patent and scientific literature.
    Donkor IO
    Expert Opin Ther Pat; 2011 May; 21(5):601-36. PubMed ID: 21434837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the therapeutic potential of calpain inhibitors: a patent review.
    Donkor IO
    Expert Opin Ther Pat; 2020 Sep; 30(9):659-675. PubMed ID: 32700591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors.
    Schiefer IT; Tapadar S; Litosh V; Siklos M; Scism R; Wijewickrama GT; Chandrasena EP; Sinha V; Tavassoli E; Brunsteiner M; Fa' M; Arancio O; Petukhov P; Thatcher GR
    J Med Chem; 2013 Aug; 56(15):6054-68. PubMed ID: 23834438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human mu-calpain by conformationally constrained calpastatin peptides.
    Pfizer J; Assfalg-Machleidt I; Machleidt W; Schaschke N
    Biol Chem; 2008 Jan; 389(1):83-90. PubMed ID: 18095873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain and calpastatin regulate neutrophil apoptosis.
    Squier MK; Sehnert AJ; Sellins KS; Malkinson AM; Takano E; Cohen JJ
    J Cell Physiol; 1999 Mar; 178(3):311-9. PubMed ID: 9989777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a new isomannide-based peptidomimetic synthetized by Ugi multicomponent reaction as human tissue kallikrein 1 inhibitor.
    Barros TG; Santos JAN; de Souza BEG; Sodero ACR; de Souza AMT; da Silva DP; Rodrigues CR; Pinheiro S; Dias LRS; Abrahim-Vieira B; Puzer L; Muri EMF
    Bioorg Med Chem Lett; 2017 Jan; 27(2):314-318. PubMed ID: 27914800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent calpain inhibitors based on the azolo-imidazolidenone scaffold.
    Gutiérrez S; Morón M; Griera M; Sucunza D; Calleros L; García-Jérez A; Coderch C; Hermoso FJ; Burgos C; Rodríguez-Puyol M; de Pascual-Teresa B; Diez-Marques ML; Jimenez A; Toro-Londoño M; Rodríguez-Puyol D; Vaquero JJ
    Eur J Med Chem; 2018 Sep; 157():946-959. PubMed ID: 30165342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling studies of peptide inhibitors highlight the importance of conformational prearrangement for inhibition of calpain.
    Jiao W; McDonald DQ; Coxon JM; Parker EJ
    Biochemistry; 2010 Jul; 49(26):5533-9. PubMed ID: 20499928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
    Cuerrier D; Moldoveanu T; Inoue J; Davies PL; Campbell RL
    Biochemistry; 2006 Jun; 45(24):7446-52. PubMed ID: 16768440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic RGD peptidomimetics containing 4- and 5-amino-cyclopropane pipecolic acid (CPA) templates as dual αVβ3 and α5β1 integrin ligands.
    Sernissi L; Trabocchi A; Scarpi D; Bianchini F; Occhiato EG
    Bioorg Med Chem; 2016 Feb; 24(4):703-11. PubMed ID: 26753814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.